What does Greg Brown invest in?

Greg Brown invests in Biotech, Healthtech, Medical Devices.

Where did Greg Brown go to school?

Greg Brown studied at Harvard Business School (MBA); Upstate Medical University (MD); Yale University (A.B.).

Greg Brown

Investor

Advisory Board - Healthcare Royalty Investing Pioneer at FemHealth Ventures · Advisor at Bering Capital

Houston, Texas, United States

Find your path to Greg

299 people in our graph share verified history with Greg — schools, employers, funds. One of them is your warm intro.

John KimunlockedGreg: together at Harvard Business School (1992)

×8Greg: together at Harvard Business School

Greg: together at Upstate Medical University

×2Greg: together at Merck

About

Gregory B. Brown, M.D. is CEO and a director of Memgen, Inc., a development-stage company working on next-generation viral immunotherapeutics including oncolytic viruses. He co-founded HCR Partners, a healthcare-focused asset management firm, and was previously a partner at Paul Capital Partners where he co-managed royalty investments; earlier he was co-head of investment banking and head of healthcare at Adams, Harkness & Hill and a biotechnology research analyst at Vector Securities International. Trained as a transplantation immunologist and thoracic and vascular surgeon, he holds a B.A. from Yale College, an M.D. from SUNY Upstate Medical Center, and an M.B.A. from Harvard Business School.

Invests in

BiotechHealthtechMedical Devices

Experience

Bering CapitalAdvisorcurrent2025 — present
AdimabDirector, ARC Boardcurrent2024 — presentLebanon, NH
FemHealth VenturesAdvisory Boardcurrent2022 — present
Gordian Group, LLCSenior Advisorcurrent2020 — presentNew York, NY
Lisata Therapeutics, Inc.Chairman Of The Boardcurrent2016 — presentBasking Ridge, New Jersey, United States
Aquestive TherapeuticsChairman of the Boardcurrent2007 — presentWarren, New Jersey, United States
HealthCare Royalty PartnersFounder & Member, Senior Advisor Board2007 — 2026Stamford, CT
MemgenChief Executive Officer2020 — 2026Houston, Texas
Faron Pharmaceuticals, OyDirector2017 — 2023Turku Metropolitan Area
FAST BioMedicalDirector2020 — 2022Indianapolis, Indiana, United States
Paul Capital PartnersPartner2003 — 2006
Adams, Harkness & HillManaging Director1997 — 2002
Vector Securities International Inc.Vice President1992 — 1997
MerckSummer Associate1991
MerckSummer Associate1991
MerckSummer Associate1991
Max, DeTraglia, Brown & Max, P.C.Partner1984 — 1990
S.U.N.Y. Upstate Medical CenterSurgical Resident1979 — 1984

Investments

Board seats

Aquestive Therapeutics, Inc.Caladrius Biosciences, Inc.Faron Pharmaceuticals OyFAST BioMedicalMemgen, Inc

Per the firm's website.

Colleagues at FemHealth Ventures

Maneesha Ghiya

Managing Partner at FemHealth Ventures

Nisha Chakravarty

Wharton Lecturer at FemHealth Ventures

Rache Simmons

Breast Cancer Surgeon at FemHealth Ventures

Randy Cohen

Harvard Business School Professor at FemHealth Ventures

Sara Crown Star

Venture Partner at FemHealth Ventures

Sean Ainsworth

Biotech CEO at FemHealth Ventures

Stephan Oppenheimer

Private Equity Investor at FemHealth Ventures

Stephanie Wang

Investor at FemHealth Ventures

Frequently asked questions

Who is Greg Brown?: Gregory B. Brown, M.D. is CEO and a director of Memgen, Inc., a development-stage company working on next-generation viral immunotherapeutics including oncolytic viruses. He co-founded HCR Partners, a healthcare-focused asset management firm, and was previously a partner at Paul Capital Partners where he co-managed royalty investments; earlier he was co-head of investment banking and head of healthcare at Adams, Harkness & Hill and a biotechnology research analyst at Vector Securities International. Trained as a transplantation immunologist and thoracic and vascular surgeon, he holds a B.A. from Yale College, an M.D. from SUNY Upstate Medical Center, and an M.B.A. from Harvard Business School.
Where does Greg Brown work?: Greg Brown is Advisory Board - Healthcare Royalty Investing Pioneer at FemHealth Ventures.
What does Greg Brown invest in?: Greg Brown invests in Biotech, Healthtech, Medical Devices.
What boards does Greg Brown sit on?: Greg Brown holds tracked board seats at Aquestive Therapeutics, Inc., Caladrius Biosciences, Inc., Faron Pharmaceuticals Oy, FAST BioMedical, Memgen, Inc.
Where did Greg Brown go to school?: Greg Brown studied at Harvard Business School (MBA); Upstate Medical University (MD); Yale University (A.B.).

Same school

Also attended Harvard Business School2,000

Brad GerstnerFounder & CEO of Altimeter Capital Victoria TreygerGeneral Partner at Felicis Ventures Deep NisharInvestment Team at General Catalyst John KimInvestor Relations at General Catalyst Adrianna MaInvestor at Index Ventures Neil RimerInvestor at Index Ventures

+ 1,994 more

Also attended Upstate Medical University2

David SchenkeinInvestor at GV (Google Ventures)Brian FenglerFounder at EvidenceCare

Also attended Yale University1,007

Ann Miura-KoCo-founding Partner at Floodgate David SzeAdvisory Partner at Greylock Michael SeibelPartner Emeritus at Y Combinator Ben SilbermannCo-founder of Pinterest Zheela QaiserInvestor at Index Ventures Anthony PhilippakisInvestor at GV (Google Ventures)

+ 1,001 more

Shared employers

+ 10 more